marketcap
Facebook
Twitter
Telegram
Report an ErrorQuarterly report 2024-Q2
added 08-14-2024
Vascular Biogenics Ltd. Financial Ratios 2011-2024 | VBLT
Annual Financial Ratios Vascular Biogenics Ltd.
| 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
P/E |
-0.0 | -0.0 | -4.4 | -4.5 | -2.8 | -2.1 | -19.5 | - | - | - | - | - | - |
P/S |
1.7 | 12.3 | 170.2 | 117.9 | 97.7 | 72.7 | 14.2 | - | - | - | - | - | - |
EPS |
-3.4 | -22.0 | 0.5 | 0.6 | 0.5 | 0.6 | - | - | - | - | - | - | - |
EV (Enterprise Value) |
-6.87 M | 5.64 M | 121 M | 106 M | 58.2 M | 50.1 M | 207 M | 132 M | 65.6 M | 19.4 T | 35.4 M | 2.55 M | - |
EBITDA per Share |
-4.36 | -19.2 | -0.43 | -0.533 | -0.51 | -0.608 | -0.383 | 0.00521 | 0.00613 | 0 | - | - | - |
EV/EBITDA |
-2.0 | -4.1 | -2.6 | -0.7 | -18.2 | 890.5 | 444.6 | 143951537.9 | - | - | - | ||
PEG |
-0.0 | -0.0 | 0.0 | 3.14 | -0.22 | 0.03 | 0.12 | - | - | - | - | - | - |
P/B |
0.0 | -0.1 | 2.5 | 3.5 | 1.5 | 0.8 | 3.5 | 3.0 | 1.8 | 553660.8 | - | - | - |
P/CF |
-0.0 | -0.0 | -5.2 | -4.6 | -4.3 | -2.4 | -19.1 | -9.2 | -4.6 | -1412317.9 | - | - | - |
ROE % |
-74.53 | 38.97 | -59.15 | -78.35 | -54.29 | -38.53 | -18.14 | - | - | - | - | - | - |
ROA % |
-57.64 | -261.42 | -46.27 | -58.09 | -40.02 | -33.72 | -15.43 | - | - | - | - | - | - |
ROCE % |
-96.98 | 34.96 | -56.45 | -71.49 | -50.17 | -37.93 | -18.33 | - | - | - | - | - | - |
Current Ratio |
4.4 | 0.8 | 5.2 | 4.3 | 4.3 | 10.8 | 7.7 | 9.7 | 9.3 | 12.9 | - | - | - |
DSO |
114.2 | 4402.8 | 45.4 | 127.5 | 133.1 | - | 65.3 | - | - | - | - | - | - |
DIO |
- | - | - | - | - | - | - | - | - | - | - | - | - |
DPO |
2323.4 | 8921.4 | 3145.5 | 1815.7 | 7456.7 | 1853.0 | 3282.9 | - | - | - | - | - | - |
Operating Cycle |
114.2 | 4402.8 | 45.4 | 127.5 | 133.1 | - | 65.3 | - | - | - | - | - | - |
Cash Conversion Cycle |
-2209.2 | -4518.6 | -3100.1 | -1688.3 | -7323.6 | -1853.0 | -3217.5 | - | - | - | - | - | - |
All numbers in USD currency
Quarterly Financial Ratios Vascular Biogenics Ltd.
| 2024-Q2 | 2024-Q1 | 2023-Q4 | 2023-Q3 | 2023-Q2 | 2023-Q1 | 2022-Q4 | 2022-Q3 | 2022-Q2 | 2022-Q1 | 2021-Q4 | 2021-Q3 | 2021-Q2 | 2021-Q1 | 2020-Q4 | 2020-Q3 | 2020-Q2 | 2020-Q1 | 2019-Q4 | 2019-Q3 | 2019-Q2 | 2019-Q1 | 2018-Q4 | 2018-Q3 | 2018-Q2 | 2018-Q1 | 2017-Q4 | 2017-Q3 | 2017-Q2 | 2017-Q1 | 2016-Q4 | 2016-Q3 | 2016-Q2 | 2016-Q1 | 2015-Q4 | 2015-Q3 | 2015-Q2 | 2015-Q1 | 2014-Q4 | 2014-Q3 | 2014-Q2 | 2014-Q1 | 2013-Q4 | 2013-Q3 | 2013-Q2 | 2013-Q1 | 2012-Q4 | 2012-Q3 | 2012-Q2 | 2012-Q1 | 2011-Q4 | 2011-Q3 | 2011-Q2 | 2011-Q1 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
EPS |
-0.55 | -0.42 | - | 0.48 | -3.54 | -6.46 | - | 4.13 | 0.12 | 0.13 | - | 0.09 | 0.12 | 0.12 | - | 0.12 | 0.14 | 0.15 | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
EBITDA per Share |
- | -0.42 | - | - | - | -5.62 | - | -4.18 | -0.12 | -0.13 | - | -0.09 | -0.12 | -0.12 | - | -0.12 | -0.14 | 0.16 | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
ROE % |
-116.88 | -36.85 | 16.14 | -20.10 | -50.52 | -85.38 | -88.05 | -101.25 | -78.22 | -65.57 | -45.62 | -61.09 | -63.35 | -62.20 | -12.19 | -12.19 | 3.28 | 16.93 | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
ROA % |
-81.76 | -48.27 | -41.34 | -41.34 | -36.25 | -40.84 | -37.05 | -47.69 | -39.80 | -51.72 | -35.90 | -35.90 | -25.27 | -13.35 | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
ROCE % |
6.46 | 12.91 | 25.85 | -17.26 | -53.91 | -88.34 | -87.97 | -100.51 | -76.40 | -62.47 | -42.96 | -58.55 | -61.59 | -61.28 | -11.51 | -11.51 | 4.07 | 17.80 | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
Current Ratio |
2.9 | 3.9 | 4.4 | 8.1 | 4.6 | 3.4 | 4.1 | - | - | 4.2 | 5.2 | 5.9 | 5.9 | 4.8 | 3.9 | - | - | - | 3.8 | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
DSO |
8372.2 | 16835.6 | - | - | - | - | - | - | - | 74.7 | - | - | - | 1.5 | - | - | - | 52.9 | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
DIO |
- | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
DPO |
- | - | - | - | - | 43526.2 | - | - | 8303.8 | 8726.0 | - | 2415.1 | 2095.2 | 1804.7 | - | - | - | 1047.8 | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
Operating Cycle |
8372.2 | 16835.6 | - | - | - | - | - | - | - | 74.7 | - | - | - | 1.5 | - | - | - | 52.9 | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
Cash Conversion Cycle |
8372.2 | 16835.6 | - | - | - | -43526.2 | - | - | -8303.8 | -8651.3 | - | -2415.1 | -2095.2 | -1803.2 | - | - | - | -994.9 | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
All numbers in USD currency